← Back to Search

Behavioral Intervention

Enhanced Milieu Teaching for Language Disorders

N/A
Recruiting
Led By Rebecca M Alper, Ph.D., CCC-SLP
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children in the Typically Developing Group (TD) must be aged 1 year 4 months - 1 year 8 months 30 days at the start of testing
Children in the DLD+ASD Group must be aged 2 years 6 months - 4 years 0 months 0 days at the start of testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (single timepoint)
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how well parents can learn how to improve their child's language skills, and what predicts how well they will do.

Who is the study for?
This trial is for children with Autism Spectrum Disorder or Language Disorder, and typically developing peers. Participants must be English dominant, have no diagnosed hearing loss, and live near Temple University in Pennsylvania or in Wisconsin. Parents need internet access for videoconferencing and must be able to consent.
What is being tested?
The study tests Enhanced Milieu Teaching (EMT), a parent training intervention aimed at improving early language skills in children at risk due to developmental disorders. It compares outcomes between those receiving EMT and a group without intervention.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, there may be varying levels of stress or frustration associated with the training process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 1 year 4 months and 1 year 8 months old.
Select...
My child is between 2.5 and 4 years old.
Select...
My child is between 2.5 and 4 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to post-treatment (five weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-treatment (five weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Parental Language Stimulation Strategies (Study 1; Remote)
Parental Language Stimulation Strategies (Study 2; Remote)
Secondary study objectives
Adult-Child Conversational Turns (Study 1; Remote)
Adult-Child Conversational Turns (Study 2; Remote)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups
Experimental Treatment
Group I: Typically Developing Children Study 2 (TD2)Experimental Treatment1 Intervention
No-intervention comparison group measured over time.
Group II: Typically Developing Children Study 1 (TD1)Experimental Treatment1 Intervention
No-intervention group for observational data comparison.
Group III: Children with Dev Language Disorder Study 2 (DLD2)Experimental Treatment1 Intervention
Enhanced Milieu Teaching
Group IV: Children with Dev Language Disorder Study 1 (DLD1)Experimental Treatment1 Intervention
No-intervention group for observational data comparison.
Group V: Children with Autism Spectrum Disorders Study 2 (ASD+DLD 2)Experimental Treatment1 Intervention
Enhanced Milieu Teaching
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Milieu Teaching
2009
N/A
~100

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,231 Previous Clinical Trials
3,199,535 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
1,051 Patients Enrolled for Autism Spectrum Disorder
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
354 Previous Clinical Trials
181,382 Total Patients Enrolled
12 Trials studying Autism Spectrum Disorder
810 Patients Enrolled for Autism Spectrum Disorder
Temple UniversityLead Sponsor
316 Previous Clinical Trials
88,942 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
286 Patients Enrolled for Autism Spectrum Disorder

Media Library

Enhanced Milieu Teaching (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03525951 — N/A
Autism Spectrum Disorder Research Study Groups: Typically Developing Children Study 2 (TD2), Children with Dev Language Disorder Study 2 (DLD2), Children with Autism Spectrum Disorders Study 2 (ASD+DLD 2), Typically Developing Children Study 1 (TD1), Children with Dev Language Disorder Study 1 (DLD1)
Autism Spectrum Disorder Clinical Trial 2023: Enhanced Milieu Teaching Highlights & Side Effects. Trial Name: NCT03525951 — N/A
Enhanced Milieu Teaching (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03525951 — N/A
~75 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top